Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Biasco

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
World Journal of Gastroenterology|May 16, 2013
Role of molecular analysis in the adjuvant treatment of gastrointestinal stromal tumours: it is time to define itMargherita Nannini, Maria A Pantaleo, Guido Biasco
Clinical Colorectal Cancer|August 24, 2011
The follow-up after radical surgery of colorectal cancer: is it time for a "tailored" strategy?Margherita Nannini, Maria Abbondanza Pantaleo, Guido Biasco
Histopathology|March 11, 2015
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumoursMargherita Nannini, Guido Biasco, Maria A Pantaleo
Journal of Pain and Symptom Management|November 16, 2010
Progress in genomic technology: a new challenge for the palliative medicine?Annalisa Astolfi, Guido Biasco, Eduardo Bruera, et al.
Expert Opinion on Therapeutic Targets|March 10, 2011
New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and futureMargherita Nannini, Guido Biasco, Alessandra Maleddu, et al.
The American Journal of Surgical Pathology|October 15, 2011
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutationsMaria A Pantaleo, Margherita Nannini, Annalisa Astolfi, et al.
Future Oncology (London, England)|November 15, 2014
Treatments for gastrointestinal stromal tumors that are resistant to standard therapiesMaristella Saponara, Maria Abbondanza Pantaleo, Margherita Nannini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Activated NF-kB in colorectal cancer: predictive or prognostic factor?Giovanni Brandi, Maria A Pantaleo, Guido Biasco, et al.
Journal of Translational Medicine|May 25, 2011
The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical settingAlessandra Maleddu, Maria A Pantaleo, Margherita Nannini, et al.
Gastrointestinal Endoscopy|May 13, 2003
Endoscopic evidence of GI hemorrhage induced by 5-fluorouracil administrationGiuseppe C Gizzi, Guido Biasco, Valeria Villani, et al.
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
World Journal of Gastroenterology|May 16, 2013
Role of molecular analysis in the adjuvant treatment of gastrointestinal stromal tumours: it is time to define itMargherita Nannini, Maria A Pantaleo, Guido Biasco
Clinical Colorectal Cancer|August 24, 2011
The follow-up after radical surgery of colorectal cancer: is it time for a "tailored" strategy?Margherita Nannini, Maria Abbondanza Pantaleo, Guido Biasco
Histopathology|March 11, 2015
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumoursMargherita Nannini, Guido Biasco, Maria A Pantaleo
Journal of Pain and Symptom Management|November 16, 2010
Progress in genomic technology: a new challenge for the palliative medicine?Annalisa Astolfi, Guido Biasco, Eduardo Bruera, et al.
Expert Opinion on Therapeutic Targets|March 10, 2011
New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and futureMargherita Nannini, Guido Biasco, Alessandra Maleddu, et al.
The American Journal of Surgical Pathology|October 15, 2011
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutationsMaria A Pantaleo, Margherita Nannini, Annalisa Astolfi, et al.
Future Oncology (London, England)|November 15, 2014
Treatments for gastrointestinal stromal tumors that are resistant to standard therapiesMaristella Saponara, Maria Abbondanza Pantaleo, Margherita Nannini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
Activated NF-kB in colorectal cancer: predictive or prognostic factor?Giovanni Brandi, Maria A Pantaleo, Guido Biasco, et al.
Journal of Translational Medicine|May 25, 2011
The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical settingAlessandra Maleddu, Maria A Pantaleo, Margherita Nannini, et al.
Gastrointestinal Endoscopy|May 13, 2003
Endoscopic evidence of GI hemorrhage induced by 5-fluorouracil administrationGiuseppe C Gizzi, Guido Biasco, Valeria Villani, et al.
Pageof 17